What is the initial workup and treatment approach for a patient with suspected anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anemia Workup

Begin the anemia workup by simultaneously ordering a complete blood count with red cell indices, reticulocyte count, iron studies panel (ferritin, transferrin saturation, total iron-binding capacity), and C-reactive protein at initial presentation. 1, 2

Diagnostic Thresholds

  • Anemia is defined as hemoglobin < 13 g/dL in men, < 12 g/dL in non-pregnant women, and < 11 g/dL in pregnant women 1, 2
  • For chronic kidney disease patients, initiate workup when hemoglobin < 12 g/dL (Hct < 37%) in adult males and post-menopausal females, and < 11 g/dL (Hct < 33%) in pre-menopausal females 1

Classification by MCV and Diagnostic Algorithm

Microcytic Anemia (MCV < 80 fL)

  • Iron deficiency anemia is confirmed by serum ferritin < 30 μg/L and transferrin saturation < 15% 3
  • In inflammatory states, ferritin up to 100 μg/L may still indicate iron deficiency—measure CRP to assess inflammation 2
  • If ferritin is 30-100 μg/L, suspect combined iron deficiency and anemia of chronic disease 2
  • Anemia of chronic disease/inflammation is diagnosed when ferritin > 100 μg/L with transferrin saturation < 20% in the presence of elevated CRP 2
  • If ferritin is elevated AND transferrin saturation is elevated, or when transferrin saturation is low with ferritin 20-100 μg/L, suspect genetic disorders of iron metabolism (sideroblastic anemia, IRIDA, hemochromatosis) 2
  • Order hemoglobin electrophoresis if iron studies are normal to evaluate for thalassemia 2

Normocytic Anemia (MCV 80-100 fL)

  • Consider acute blood loss, hemolysis, anemia of chronic disease, early iron deficiency, or chronic kidney disease 1, 2
  • Use reticulocyte count to distinguish between impaired production (low reticulocyte count) and increased destruction or blood loss (elevated reticulocyte count) 2
  • Check lactate dehydrogenase, haptoglobin, and bilirubin if hemolysis is suspected 4

Macrocytic Anemia (MCV > 100 fL)

  • Check vitamin B12 and folate levels to identify deficiency states 1, 2
  • Consider medications, alcohol use, or myelodysplastic syndrome as alternative causes 1, 2

Treatment Approach by Etiology

Iron Deficiency Anemia

  • Oral iron supplementation is first-line treatment, with parenteral iron reserved for patients who cannot tolerate or absorb oral preparations 3
  • All adults with confirmed iron deficiency anemia require urinalysis/urine microscopy, celiac disease screening, and in appropriate cases, upper and lower GI endoscopy 2
  • Men and postmenopausal women with iron deficiency anemia must undergo gastrointestinal endoscopy to identify the source 5

Vitamin B12 Deficiency (Pernicious Anemia)

  • Administer 100 mcg intramuscular or deep subcutaneous cyanocobalamin daily for 6-7 days, then alternate days for seven doses, then every 3-4 days for 2-3 weeks, followed by 100 mcg monthly for life 6
  • Avoid the intravenous route as almost all vitamin will be lost in urine 6
  • Administer folic acid concomitantly if needed 6

Folate Deficiency

  • Treat with oral folate supplementation, but ensure B12 deficiency is excluded first to avoid masking B12 deficiency symptoms 3

Anemia of Chronic Disease/Inflammation

  • Primary treatment involves addressing the underlying condition 2
  • Iron supplementation, folic acid, and vitamin B12 may be needed based on specific deficiencies identified 7

Anemia in Chronic Kidney Disease

  • Monitor hemoglobin at least every 3 months in patients with GFR < 30 mL/min/1.73 m² 1, 3
  • Initiate full workup if hemoglobin drops below thresholds (< 12 g/dL in women, < 13 g/dL in men) 2, 3
  • Treat identified iron deficiency first; if anemia persists despite iron repletion, initiate erythropoietin or analogue therapy 1, 3
  • Measuring serum erythropoietin levels is usually not indicated in chronic kidney disease patients with normochromic, normocytic anemia 3

Special Population Considerations

Inflammatory Bowel Disease

  • Anemia is typically multifactorial (iron deficiency from blood loss plus anemia of chronic disease) 2
  • Use disease-specific ferritin thresholds: < 30 μg/L without inflammation, up to 100 μg/L with inflammation 2
  • Minimum screening should include CBC, CRP, and serum ferritin at regular intervals based on disease activity 2

Elderly Patients

  • Never assume anemia is "normal aging"—always investigate the underlying cause 1, 3
  • Watch for combined deficiencies, such as iron and B12 deficiency, which are common in this population 1, 3

Critical Pitfalls to Avoid

  • Ferritin interpretation requires clinical context, as it can be falsely elevated in inflammation, chronic disease, malignancy, or liver disease 1
  • Watch for combined nutritional deficiencies, especially in elderly patients and those with inflammatory bowel disease 1, 3
  • Consider genetic disorders when microcytic anemia is refractory to iron supplementation, there is a family history of anemia, or ferritin > 100 μg/L with elevated transferrin saturation 2
  • For X-linked sideroblastic anemia, screen male probands' mothers, sisters, and daughters, as female carriers can develop phenotype later in life 2

References

Guideline

Anemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach and Management of Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anemia Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Anemia: Evaluation of Suspected Anemia.

FP essentials, 2023

Research

Iron deficiency anemia: evaluation and management.

American family physician, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.